Approx.280 pages
- Discusses underlying cellular and molecular mechanisms altered in protein-associated neurodegenerative disorders
- Describes methods for detection and analysis of protein aggregates
- Features advancements in therapeutics and emerging techniques to treat these disorders
- Covers implications in a variety of neurodegenerative diseases, including Alzheimer's, Parkinson's, ALS, Creutzfeldt-Jakob disease, Cystic fibrosis, Gaucher's disease, and Polyglutamine diseases, including Huntington's and other related proteinopathies
